Loading
John V. Oyler received $5.6M in total compensation as CEO of BeOne Medicines Ltd. in FY2025. The largest component was $3.7M in option awards. That’s down 73% from FY2024. Source: SEC DEF 14A.
In fiscal year 2025, John V. Oyler, CEO of BeOne Medicines Ltd. (ONC), received total compensation of $5.6 million.
John V. Oyler's compensation breakdown includes: option awards of $3.7 million, non-equity incentive compensation of $1.7 million, and other compensation of $134K.
Compared to fiscal year 2024, John V. Oyler's total compensation decreased 73% from $20.8 million to $5.6 million.
BeOne Medicines Ltd.'s top 5 named executive officers received combined total compensation of $15.1 million in fiscal year 2025.
The named executive officers disclosed in BeOne Medicines Ltd.'s 2025 proxy statement are:John V. Oyler with total compensation of $5.6 million, Xiaobin Wu with total compensation of $3.7 million, Lai Wang with total compensation of $2.4 million, Aaron Rosenberg with total compensation of $1.9 million, and Chan Lee (Senior) with total compensation of $1.6 million.
John V. Oyler of BeOne Medicines Ltd. (ONC), received $5,560,636 in total compensation for FY2025, down 73.3% from the prior year. Option awards of $3,749,967 were the largest component. Figures come from BeOne Medicines Ltd.'s DEF 14A 0001104659-26-049655 filed 28 Apr 2026.
Source Filing
Executive Record
John V. Oyler
Reported Pay
$5.6MSummary compensation table total · FY2025
Findings
Reviewing FY2025 compensation of $5.6M against +65% shareholder return and the latest filing-backed pay disclosures.
Reported pay changed -73%; spread versus stock performance is pending computation.
Evidence is sourced from the latest executive compensation filing and return series for ONC.
BeOne Medicines Ltd. (ONC) — Key Facts
Last updated Jun 25, 2026 · DEF 14A filed Apr 28, 2026
| CEO | John V. Oyler |
|---|---|
| Fiscal year | FY2025 |
| Total compensation | $5.6M |
| Other compensation | $134K |
| Year-over-year change | -73% |
| Source | DEF 14A, 2026-04-28 |
John V. Oyler, the CEO of BeOne Medicines Ltd., received total compensation of $5,560,636 in fiscal year 2025.. Figures come from BeOne Medicines Ltd.'s DEF 14A 0001104659-26-049655 filed 28 Apr 2026.
John V. Oyler's base salary at BeOne Medicines Ltd. is not separately disclosed. Total compensation for fiscal year 2025 was $5,560,636. Figures come from BeOne Medicines Ltd.'s DEF 14A 0001104659-26-049655 filed 28 Apr 2026.
BeOne Medicines Ltd.'s CEO, John V. Oyler, earned $5,560,636 in total compensation for fiscal year 2025. Figures come from BeOne Medicines Ltd.'s DEF 14A 0001104659-26-049655 filed 28 Apr 2026.
Reading filings for ONC...
Reading the latest proxy statement
Calculating CEO-to-worker ratio
Checking insider sales and trading plans